A study comparing the effectiveness of an on-line mindfulness and muscle relaxation treatment for chronic headache, compared to mindfulness or muscle relaxation alone, among people from a Russian ethnic background.

A randomised controlled trial comparing the differential effectiveness of an on-line mindfulness and progressive muscle relaxation treatment for chronic headache versus mindfulness or progressive muscle relaxation alone, in a Russian ethnic background sample

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN69863201

Enrollment

Registered

2013-04-29

Start date

2013-03-04

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic headache and migraine Nervous System Diseases Migraine, unspecified

Interventions

Upon completion of baseline measures, participants will be randomised to one of three conditions: 1. Mindfulness based treatment 2. Mindfulness and progressive muscle relaxation treatment combined 3.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Male and female, over 18 years of age 2. Ethnic background - Russian 3. Knowledge of the Russian language - fluent 4. A headache is present on at least 15 days a month for 3 months

Exclusion criteria

Exclusion criteria: 1. Under 18 years of age 2. Ethnic background: other than Russian 3. Knowledge of the Russian language: less than fluent 4. Psychological disorder diagnosis 5. Uncontrolled blood pressure

Design outcomes

Primary

Measure	Time frame
1. Brief Pain Inventory Short Form (SF) 2. Chronic Pain Acceptance Questionnaire SF-8 Baseline timepoint is prior to participation in the intervention. The intervention will be conducted for the duration of 6 weeks. 4 weeks follow up will be conducted at 4 weeks after the participant has completed the programme. 3 months follow up will be conducted at 3 months after the participant has completed the programme.	—

Measure

Time frame

1. Brief Pain Inventory Short Form (SF) 2. Chronic Pain Acceptance Questionnaire SF-8 Baseline timepoint is prior to participation in the intervention. The intervention will be conducted for the duration of 6 weeks. 4 weeks follow up will be conducted at 4 weeks after the participant has completed the programme. 3 months follow up will be conducted at 3 months after the participant has completed the programme.

—

Secondary

Measure	Time frame
1. Brief Illness Belief Questionnaire 2. Leeds Dependence Questionnaire (adapted for medication dependence) 3. Kentucky Inventory of Mindfulness Skills (attention subscale) 4. Pain Catastrophising Scale 5. Social Support Questionnaire SF-12 6. Hospital Anxiety and Depression Scale 7. Headache Specific Locus of Control Scale SF-9 Baseline timepoint is prior to participation in the intervention. The intervention will be conducted for the duration of 6 weeks. 4 weeks follow up will be conducted at 4 weeks after the participant has completed the programme. 3 months follow up will be conducted at 3 months after the participant has completed the programme.	—

Measure

Time frame

1. Brief Illness Belief Questionnaire 2. Leeds Dependence Questionnaire (adapted for medication dependence) 3. Kentucky Inventory of Mindfulness Skills (attention subscale) 4. Pain Catastrophising Scale 5. Social Support Questionnaire SF-12 6. Hospital Anxiety and Depression Scale 7. Headache Specific Locus of Control Scale SF-9 Baseline timepoint is prior to participation in the intervention. The intervention will be conducted for the duration of 6 weeks. 4 weeks follow up will be conducted at 4 weeks after the participant has completed the programme. 3 months follow up will be conducted at 3 months after the participant has completed the programme.

—

Countries

Russian Federation

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026